Literature DB >> 31901445

The circular RNA HIPK3 (circHIPK3) and its regulation in cancer progression: Review.

Yimin Xie1, Xuefeng Yuan1, Weimin Zhou1, Anthony Adebayiga Kosiba2, Haifeng Shi2, Jie Gu2, Zhenqian Qin3.   

Abstract

Circular RNAs (circRNAs) are a class of covalently closed continuous loops of single-stranded RNA molecules, and broadly expressed in the cytoplasm of eukaryotic cells. CircRNAs have attracted considerable research attention in recent years, an attention primarily attributed to their critical roles in the development and progression of diseases, especially in cancers. The circRNA homeodomain-interacting protein kinase 3 (circHIPK3) is a recently identified circRNA, acknowledged to be relevant to human pathology and cancer progression. Here, we summarize the origin and functions of the circHIPK3 and its target molecules in cancer, and thus, providing a broader knowledge to our current understanding of circRNAs. This review will therefore be essential to enriching our knowledge on the roles of circRNAs in cancers by outlining their potential values and application in the diagnosis and treatment of cancer.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Cancer; CircHIPK3; CircRNA; MicroRNA; Tumor progression

Mesh:

Substances:

Year:  2020        PMID: 31901445     DOI: 10.1016/j.lfs.2019.117252

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

1.  CircHIPK3 Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Cells Proliferation and Metastasis via Altering of miR-508-3p/CXCL13 Signal.

Authors:  Bin Han; E Shaolong; Lan Luan; Nanyang Li; Xuefeng Liu
Journal:  Onco Targets Ther       Date:  2020-06-25       Impact factor: 4.147

Review 2.  Biogenesis, cellular effects, and biomarker value of circHIPK3.

Authors:  Yihan Fu; Hong Sun
Journal:  Cancer Cell Int       Date:  2021-05-11       Impact factor: 5.722

3.  Regulation of MRP4 Expression by circHIPK3 via Sponging miR-124-3p/miR-4524-5p in Hepatocellular Carcinoma.

Authors:  Haihong Hu; Yu Wang; Zhiyuan Qin; Wen Sun; Yanhong Chen; Jiaqi Wang; Yingying Wang; Jing Nie; Lu Chen; Sheng Cai; Lushan Yu; Su Zeng
Journal:  Biomedicines       Date:  2021-04-30

Review 4.  Functional and Clinical Impact of CircRNAs in Oral Cancer.

Authors:  Ion Cristóbal; Cristina Caramés; Jaime Rubio; Marta Sanz-Alvarez; Melani Luque; Juan Madoz-Gúrpide; Federico Rojo; Jesús García-Foncillas
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

5.  The Regulatory Role of circRNA_101308 in Cervical Cancer and the Prediction of Its Mechanism.

Authors:  Jun Jiao; Xinlin Jiao; Qingqing Liu; Wenjie Qu; Daoxin Ma; Youzhong Zhang; Baoxia Cui
Journal:  Cancer Manag Res       Date:  2020-06-22       Impact factor: 3.989

6.  CircHIPK3 promotes proliferation and metastasis and inhibits apoptosis of renal cancer cells by inhibiting MiR-485-3p.

Authors:  Jinjin Lai; Jun Xin; Changde Fu; Wei Zhang
Journal:  Cancer Cell Int       Date:  2020-06-16       Impact factor: 5.722

7.  CircHIPK3 Promotes Pyroptosis in Acinar Cells Through Regulation of the miR-193a-5p/GSDMD Axis.

Authors:  Jiale Wang; Xia Li; Yunfei Liu; Cheng Peng; Hongwei Zhu; Guangping Tu; Xiao Yu; Zhiqiang Li
Journal:  Front Med (Lausanne)       Date:  2020-04-07

8.  Cerina: systematic circRNA functional annotation based on integrative analysis of ceRNA interactions.

Authors:  Jacob Cardenas; Uthra Balaji; Jinghua Gu
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

9.  Circular RNA circHIPK3 Promotes Cell Metastasis through miR-637/STAT3 Axis in Osteosarcoma.

Authors:  Zhongyue Huang; Chunyan Yuan; Huijie Gu; Xiangyang Cheng; Kaifeng Zhou; Jun Xu; Xiaofan Yin; Jiangni Xia
Journal:  Biomed Res Int       Date:  2020-07-24       Impact factor: 3.411

10.  CircHIPK3 Alleviates High Glucose Toxicity to Human Renal Tubular Epithelial HK-2 Cells Through Regulation of miR-326/miR-487a-3p/SIRT1.

Authors:  Langen Zhuang; Ziwei Wang; Xiaolei Hu; Qingqing Yang; Xiaoyan Pei; Guoxi Jin
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-17       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.